Latest Kyowa Kirin News & Updates

See the latest news and media coverage for Kyowa Kirin. We track all announcements, press releases, and industry mentions in real time, all in one place.

Kyowa Kirin

Global specialty pharmaceutical company

kyowakirin.com

Headquarters: Chiyoda-ku, Japan
Company type: Public company
Number of employees: 5,000–10,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Kyowa Kirin

In short: Kyowa Kirin appointed Abdul Mullick as CEO, discontinued high-profile trials for rocatinlimab, and reported strong global sales growth.

Company announcements

July 13 Kyowa Kirin

Kyowa Kirin announces CEO transition

Chairman Masashi reflects on global expansion while CEO Abdul commits to building a Super Team.

July 2 Kyowa Kirin

Kyowa Kirin highlights publication of Phase 3 infigratinib trial in NEJM

The PROPEL 3 study met its primary endpoint and showed significant height velocity improvement in children with achondroplasia.

June 30 Kyowa Kirin

Kyowa Kirin selected for FDA PreCheck Pilot Program

The program aims to accelerate manufacturing timelines and enhance supply chain resilience at its new Sanford, NC facility.

June 30 Kyowa Kirin

Kyowa Kirin announces CEO transition from Miyamoto to Mullick

Miyamoto reflects on eight years of growth and global expansion, while Mullick takes over to continue delivering patient value.

Media coverage

July 20 AFP

European Commission approves Crysvita® (burosumab) for infants with ...

Kyowa Kirin EMEA, a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE: 4151), announced today that the European Commission (EC) had approved...

July 15 Sankei News

Toward the acquisition of shares (subsidiarization) of Kyowa Pharma Chemical Co., Ltd. ...

Dai Nippon Printing Co., Ltd. (Head office: Tokyo; Representative Director and President: Yoshinori Kitajima; hereinafter DNP) concluded a share transfer agreement on July 15, 2026 with Kyowa Hakko Bio Co., Ltd., a shareholder, and its parent company Kirin Holdings Co., Ltd., for the purpose of making Kyowa Pharma Chemical Co., Ltd. (Head office: Toyama Prefecture; Representative Director and President: Isao Miyoshi; hereinafter Kyowa Pharma), which handles active pharmaceutical ingredient manufacturing, a subsidiary. DNP will acquire shares of Kyowa Pharma in October 2026 ...

July 7 Nikkei

Kyowa Kirin: Notice Regarding Change in Management Structure (CEO Succession)

You may not be able to view this comfortably in your browser. Please use Microsoft Edge or Chrome. This content is for paid members only. To view it, you need to register as a paid member...

July 6 Yahoo Finance

FDA Selects Kyowa Kirin for PreCheck Pilot Program to Accelerate Manufacturing Timelines and Enhance Supply Chain Resilience

Strategic collaboration at Sanford, North Carolina facility, currently under construction, to optimize cGMP validation, accelerate time-to-market for complex biologics, and shore up U.S. medicine ...

Never miss news about Kyowa Kirin

Track Kyowa Kirin and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Kyowa Kirin competitors & trending companies

Browse news for competitors to Kyowa Kirin and other trending companies.